ATE263239T1 - Produkte des keratinocyten-wachstumsfaktors 2 (kgf-2) - Google Patents
Produkte des keratinocyten-wachstumsfaktors 2 (kgf-2)Info
- Publication number
- ATE263239T1 ATE263239T1 AT97910119T AT97910119T ATE263239T1 AT E263239 T1 ATE263239 T1 AT E263239T1 AT 97910119 T AT97910119 T AT 97910119T AT 97910119 T AT97910119 T AT 97910119T AT E263239 T1 ATE263239 T1 AT E263239T1
- Authority
- AT
- Austria
- Prior art keywords
- kgf
- growth factor
- keratinocyte growth
- products
- variants
- Prior art date
Links
- 102000004864 Fibroblast growth factor 10 Human genes 0.000 title abstract 4
- 108090001047 Fibroblast growth factor 10 Proteins 0.000 title abstract 4
- 239000000126 substance Substances 0.000 abstract 2
- 230000008556 epithelial cell proliferation Effects 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Pulmonology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2849396P | 1996-10-15 | 1996-10-15 | |
| US3278196P | 1996-12-06 | 1996-12-06 | |
| US3304696P | 1996-12-11 | 1996-12-11 | |
| PCT/US1997/018607 WO1998016642A1 (en) | 1996-10-15 | 1997-10-15 | Keratinocyte growth factor-2 products |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE263239T1 true ATE263239T1 (de) | 2004-04-15 |
Family
ID=27363281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97910119T ATE263239T1 (de) | 1996-10-15 | 1997-10-15 | Produkte des keratinocyten-wachstumsfaktors 2 (kgf-2) |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0935652B1 (de) |
| JP (2) | JP2001506975A (de) |
| AT (1) | ATE263239T1 (de) |
| AU (1) | AU727678C (de) |
| CA (1) | CA2269077C (de) |
| DE (2) | DE69728415T2 (de) |
| DK (1) | DK0935652T3 (de) |
| ES (1) | ES2218666T3 (de) |
| GB (1) | GB2322132B (de) |
| PT (1) | PT935652E (de) |
| WO (1) | WO1998016642A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6693077B1 (en) | 1995-02-14 | 2004-02-17 | Human Genome Sciences, Inc. | Keratinocyte growth factor-2 |
| US6077692A (en) | 1995-02-14 | 2000-06-20 | Human Genome Sciences, Inc. | Keratinocyte growth factor-2 |
| US7232667B2 (en) | 1995-02-14 | 2007-06-19 | Human Genome Sciences, Inc. | Keratinocyte growth factor-2 polynucleotides |
| CA2263143A1 (en) * | 1996-08-13 | 1998-02-19 | Human Genome Sciences, Inc. | Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, fgf-12) |
| EP1452205B1 (de) * | 1996-10-15 | 2007-11-28 | Amgen Inc. | Verwendung von keratinocyte growth factor-2 |
| EP1041996A4 (de) | 1997-12-22 | 2003-05-14 | Human Genome Sciences Inc | Keratinozyten wachstumsfaktor-2 formulierungen |
| US6869927B1 (en) | 1997-12-22 | 2005-03-22 | Human Genome Sciences, Inc. | Keratinocyte growth factor-2 formulations |
| US6372494B1 (en) | 1999-05-14 | 2002-04-16 | Advanced Tissue Sciences, Inc. | Methods of making conditioned cell culture medium compositions |
| AU5593200A (en) * | 1999-06-02 | 2000-12-18 | Human Genome Sciences, Inc. | Keratinocyte growth factor-2 formulations |
| NZ516897A (en) * | 1999-07-02 | 2004-01-30 | Human Genome Sciences Inc | Polynucleotides and associated polypeptides for KGF-2 (also known as Fibroblast Growth Factor 12) to promote and accelerate internal and external wound healing |
| EP1404713A4 (de) * | 2001-05-24 | 2004-09-22 | Human Dna Technology Inc | Neues keratinocyte growth factor 2 analogon in haarfollikeln |
| WO2002098365A2 (en) * | 2001-06-07 | 2002-12-12 | Skinmedica, Inc. | Conditioned cell culture media and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ266622A (en) * | 1993-06-29 | 1997-10-24 | Chiron Corp | Keratinocyte growth factor fragment (kgf) with at least a 2-fold increase in mitogenic activity compared to a full length kgf; dna molecules, expression vectors, host cells, and conjugates |
| DE69521789T2 (de) * | 1994-02-01 | 2002-04-25 | The United States Of Amerika Represented By The Secretary, Department Of Health And Human | Fusionierte proteine die antikörper-teile und nicht-antikörper-teile enthalten |
| SI0785950T1 (en) * | 1994-10-13 | 2003-08-31 | Amgen Inc. | Keratinocyte growth factor analogs |
| EP0804479B1 (de) * | 1994-10-13 | 2006-10-11 | Amgen Inc., | Verfahren zur behandlung von diabetes mittels kgf |
| DK0815115T3 (da) * | 1995-02-14 | 2003-09-15 | Human Genome Sciences Inc | Keratinocytvækstfaktor-2 |
| CA2263143A1 (en) * | 1996-08-13 | 1998-02-19 | Human Genome Sciences, Inc. | Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, fgf-12) |
-
1997
- 1997-10-15 DE DE69728415T patent/DE69728415T2/de not_active Expired - Lifetime
- 1997-10-15 JP JP51856598A patent/JP2001506975A/ja active Pending
- 1997-10-15 GB GB9811279A patent/GB2322132B/en not_active Revoked
- 1997-10-15 DK DK97910119T patent/DK0935652T3/da active
- 1997-10-15 PT PT97910119T patent/PT935652E/pt unknown
- 1997-10-15 EP EP97910119A patent/EP0935652B1/de not_active Expired - Lifetime
- 1997-10-15 WO PCT/US1997/018607 patent/WO1998016642A1/en not_active Ceased
- 1997-10-15 AT AT97910119T patent/ATE263239T1/de active
- 1997-10-15 CA CA002269077A patent/CA2269077C/en not_active Expired - Fee Related
- 1997-10-15 AU AU47576/97A patent/AU727678C/en not_active Ceased
- 1997-10-15 DE DE19781038T patent/DE19781038T1/de not_active Withdrawn
- 1997-10-15 ES ES97910119T patent/ES2218666T3/es not_active Expired - Lifetime
-
2008
- 2008-06-16 JP JP2008157291A patent/JP2008283980A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| DE69728415T2 (de) | 2004-08-12 |
| DE19781038T1 (de) | 1998-12-10 |
| JP2001506975A (ja) | 2001-05-29 |
| DK0935652T3 (da) | 2004-07-26 |
| GB9811279D0 (en) | 1998-07-22 |
| PT935652E (pt) | 2004-07-30 |
| CA2269077C (en) | 2004-04-06 |
| EP0935652A1 (de) | 1999-08-18 |
| AU727678C (en) | 2005-05-12 |
| WO1998016642A1 (en) | 1998-04-23 |
| AU727678B2 (en) | 2000-12-21 |
| DE69728415D1 (de) | 2004-05-06 |
| GB2322132B (en) | 1999-09-22 |
| HK1022714A1 (en) | 2000-08-18 |
| GB2322132A (en) | 1998-08-19 |
| AU4757697A (en) | 1998-05-11 |
| EP0935652B1 (de) | 2004-03-31 |
| CA2269077A1 (en) | 1998-04-23 |
| JP2008283980A (ja) | 2008-11-27 |
| ES2218666T3 (es) | 2004-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT101297A (pt) | Factores mitogenicos gliais, sua preparacao e utilizacao | |
| BG102071A (en) | Minor molecule inhibitors of rotamase enzymic activity | |
| DE69029657D1 (de) | Menschliches cytokin, interleukin-9 | |
| IL117425A0 (en) | Receptor activation by gas6 | |
| DE69942459D1 (de) | Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung | |
| ATE449850T1 (de) | Mutanten von flt3-l und ihre verwendungen | |
| DE69728415D1 (de) | Produkte des keratinocyten-wachstumsfaktors 2 (kgf-2) | |
| ES2133813T3 (es) | Cadenas de lamininas: diagnostico y uso terapeutico. | |
| BG101408A (bg) | Аналози на кератиноцитния растежен фактор | |
| CY1109207T1 (el) | Διαδικασια εχινοκανδινης | |
| ATE256740T1 (de) | Menschliches sdf-5 protein und diesbezügliche zusammensetzungen | |
| ATE320488T1 (de) | Mutanten des lag-3 proteins, ihre expression und verwendung | |
| WO1997026322A3 (en) | Methods and compositions for inhibiting hexokinase | |
| HUT43106A (en) | Dns sequences koding proteins of flesh-i type inhibitor activity and process for producing these proteins | |
| DK1082423T3 (da) | Cyclin E2-gener og -proteiner | |
| DE69808475D1 (de) | Aminosäurederivate zur behandlung von schlaganfall | |
| WO1997008934A3 (en) | Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors | |
| DE69931759D1 (de) | Methode zur erstellung von genexpressionsprofilen | |
| DK0977859T3 (da) | Den neurotrofiske faktor NNT-1 | |
| ATE338768T1 (de) | Muc-1 derivate und deren verwendung zur behandlung von krebsassoziierter muc-1 mucin induzierter immunosuppression | |
| ES2117717T3 (es) | Tratamiento de tumores con factores neurotroficos e inhibidores de la proliferacion celular. | |
| ATE376586T1 (de) | Ppgpp-synthetase und expressionssysteme zur verbesserten herstellung von proteinen | |
| ATE389014T1 (de) | Phosphorylierte glyoxalase i und deren verwendung | |
| SE9604439D0 (sv) | New receptor | |
| FR2654430B1 (fr) | Nouveaux derives de peptides, utilisables comme inhibiteurs des collagenases bacteriennes. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0935652 Country of ref document: EP |
|
| EEIH | Change in the person of patent owner |